C84.97
Mature T/NK-cell lymphomas, unspecified, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Mature T/NK-cell lymphomas of the spleen are rare types of blood cancers that originate from T-cells or natural killer (NK) cells, which are crucial components of the immune system. When these cancers involve the spleen, they can cause a range of health issues, including enlargement of the spleen and related symptoms. The ICD-10 code C84.97 specifically categorizes these lymphomas when their exact subtype is unspecified, focusing on the occurrence in the spleen. Understanding this condition involves exploring its causes, symptoms, diagnostic procedures, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cell or NK-cell growth and development Chronic immune system stimulation or inflammation Viral infections, notably Epstein-Barr virus (EBV) and Human T-lymphotropic virus (HTLV-1) Exposure to certain chemicals or environmental toxins Pre-existing immune deficiencies or autoimmune disorders
Key Symptoms: Enlarged spleen (splenomegaly), which may cause a feeling of fullness or discomfort in the upper left abdomen Unexplained weight loss Persistent fever Night sweats Fatigue and weakness Frequent infections due to immune suppression Lymphadenopathy, or swollen lymph nodes in other parts of the body Anemia, leading to pallor or shortness of breath
Diagnostic & Treatment
Diagnosis Path: Physical examination to detect spleen enlargement and lymph node swelling Blood tests, including complete blood count (CBC) and blood chemistry Imaging studies such as ultrasound, CT scans, or MRI to evaluate spleen size and internal structures Biopsy of the spleen or affected lymph nodes for histopathological analysis Immunophenotyping to identify specific cell markers characteristic of T or NK cells Molecular studies, including gene rearrangement assays, to detect genetic abnormalities Bone marrow biopsy to assess marrow involvement
Treatment Protocols: Chemotherapy regimens tailored to peripheral T-cell lymphomas Targeted therapy aimed at specific molecular markers or pathways Immunotherapy to boost the body's ability to fight the cancer Radiation therapy, primarily in localized disease or for symptom relief Stem cell transplantation in eligible patients to consolidate remission Supportive care, including transfusions and infection management
Clinical Advice & FAQs
Billing Guidance
Is C84.97 a billable ICD-10 code?
Yes, C84.97 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.97?
Clinical documentation must specify the nature of Mature T/NK-cell lymphomas, unspecified, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference